Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis

Liver International

Volumn 25, Issue 1, 2005, Pages 57-61

  Cholongitas, Evangelos ^a   Papatheodoridis, George V ^a   Lahanas, Alexandros ^b   Xanthaki, Anna ^b   Kontou Kastellanou, Chrysoula ^b   Archimandritis, Athanasios J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Cirrhosis; Gram negative bacteria; Gram positive bacteria; Quinolone resistance; Spontaneous bacterial peritonitis

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ASCITES FLUID ANALYSIS; BACTERIAL PERITONITIS; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MALE; NEUTROPHIL; RETROSPECTIVE STUDY;

AGED; ANTI-INFECTIVE AGENTS; ASCITES; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONITIS; QUINOLONES;

EID: 14544301866     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0985.x     Document Type: Article

References (17)

1. Arroyo V, Jimenez W. Complications of cirrhosis II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000; 32(Suppl. 1): 157-70.
2. Gaurner C, Runyon B A. Macrophage function in cirrhosis and the risk of bacterial infection. Hepatology 1995; 22: 367-9.
3. Gaurner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997; 17: 203-17.
4. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142-53.
5. Aparicio J R, Such J, Pascual S, et al. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 1999; 31: 277-83.
6. Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
7. Cereto F, Genesca J, Smithson A, et al. Spontaneous bacterial peritonitis caused by quinolone-resistant Escherichia coli: could steroid therapy play a role? Eur J Gastroenterol Hepatol 2002; 14: 81-3.
8. Campillo B, Dupeyron C, Richardet J P. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 2001; 127: 443-50.
9. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001; 120: 726-48.
10. Novella M T, Sola R, Soriano G, et al. Continuous vs inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997; 25: 532-6.
11. Grange J D, Bernard B, Nguyen E, Opolon P, Poynard T. Antibiotic prophylaxis (ApP) for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding (GB): a meta-analysis (abstract). Hepatology 1996; 24: 1272A.
12. Ortiz J, Vila M C, Soriano G, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 1999; 29: 1064-9.
13. Llovet J M, Rodriguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol 1997; 26: 88-95.
14. Carratala J, Fernandez-Sevilla A, Tubau F, Dominuez M A, Gudiol F. Emergence of fluorquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norphloxacin prophylaxis. Antimicrob Agents Chemother 1996; 40: 503-5.
15. Ruynon B. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-56.
16. Campillo B, Dupeyron C, Richardet J P, Mangeney N, Leluan G. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long term administration of norfloxacin. Clin Infect Dis 1998; 26: 1066-70.
17. Evans L, Kim W R, Poterucha J J, Kamath P. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 2003; 37: 897-901.